Action of systemic apomorphine on dopamine cell firing after neostriatal kainic acid lesion.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001545:Benserazide / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects*; D004292:Dominance, Cerebral / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005071:Evoked Potentials / Q000187:drug effects; D007608:Kainic Acid / Q000633:toxicity*; D008297:Male; D009434:Neural Pathways / Q000187:drug effects; D009474:Neurons / Q000187:drug effects; D011759:Pyrrolidines / Q000633:toxicity*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects; D013378:Substantia Nigra / Q000187:drug effects*
D011759:Pyrrolidines; D011954:Receptors, Dopamine; D001545:Benserazide; D001058:Apomorphine; D007608:Kainic Acid; D004298:Dopamine